Tranylcypromine hydrochloride is an irreversible inhibitor of lysine-specific demethylase 1 (LSD1/BHC110) and monoamine oxidase (MAO). It effectively inhibits LSD1, MAO A, and MAO B with specified IC50s. This compound is utilized for research applications, particularly those related to depression.
- Irreversible inhibitor of lysine-specific demethylase 1 (LSD1/BHC110).
- Irreversible inhibitor of monoamine oxidase (MAO).
- Inhibits LSD1 with an IC50 of 20.7 μM.
- Inhibits MAO A with an IC50 of 2.3 μM.
- Inhibits MAO B with an IC50 of 0.95 μM.
- Suitable for research related to depression.
- Supplied as a white to yellow solid.
- Requires sealed storage at 4°C, away from moisture.
- Shows specific derepression of OCT4 transcription in vitro.
- Decreases LPS-mediated microglial activation in vivo.
- Down-regulates Aβ-mediated microglial activation in vivo.